Alkem Laboratories Share Price
Mid Cap | Pharmaceuticals and health care | NSE: ALKEM | BSE: 539523
₹4,605.65 
-121.40 (-2.57 %)
Last Updated: 21 Feb 2025 04:01 PM
BEARISH
Overview
Open (₹) 4,760.95
High (₹) 4,760.95
Low (₹) 4,589.00
Prev. Close (₹) 4,727.05
Volume 3,314
VWAP (₹) 4,621.32
ROCE (%) 19.49
Industry P/E 43.99
TTM P/E 25.58
P/B Ratio 5.13
Market Cap (₹) Cr.55,014.85
Dividend Yield (%)0.87
EPS (₹) 150.19
ROE16.76%
Sales Growth (%) 9.21
Profit Growth (%)79.92
Day Range
4,760.954,760.95
52 Week Range
4,409.906,440.00
Historical Returns
Returns (6M)
-20.85 %
Returns (1Y)
-15.02 %
Returns (3Y)
41.32 %
Returns (5Y)
77.12 %
Returns (6M)
-20.85 %
Returns (1Y)
-15.02 %
Returns (3Y)
41.32 %
Returns (5Y)
77.12 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (82.47%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 82.47% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
Technicals
Technical Rating
BEARISHRSI 38.09
MFI 54.64
ATR 161.72
Commodity Channel Index -93.52
ROC125 -19.98
ROC21 -8.38
Williams %R -94.32
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 4,714.74 | 4,823.82 | 4,886.69 | 4,651.87 | 4,542.79 | 4,479.92 | 4,370.84 |
| Week Ago | 4,710.61 | 4,767.38 | 4,827.66 | 4,650.33 | 4,593.56 | 4,533.28 | 4,476.51 |
| Month Ago | 5,260.90 | 5,346.15 | 5,396.60 | 5,210.45 | 5,125.20 | 5,074.75 | 4,989.50 |
EMA & SMA
4605.65
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 4739.82
9 Day 4710.26
10 Day 4733.50
12 Day 4865.00
14 Day 4879.12
20 Day 4898.71
26 Day 4969.99
50 Day 5193.05
100 Day 5512.21
200 Day 5483.39
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| RAJESH KUMAR | bulk | Sell | 18 Jun, 2024 | ₹4,950.22 | 10,00,000 | BSE |
| RAJEEV RANJAN | bulk | Sell | 18 Jun, 2024 | ₹4,950.00 | 10,00,000 | BSE |
| MARSHALL WACE INVESTMENT STRATEGIES - EUREKA FUND | block | Sell | 26 Apr, 2024 | ₹4,867.65 | 1,03,803 | BSE |
| SOCIETE GENERALE | block | Buy | 26 Apr, 2024 | ₹4,867.65 | 1,03,803 | BSE |
| BNP PARIBAS ARBITRAGE | block | Sell | 25 Jan, 2024 | ₹4,999.60 | 3,08,994 | BSE |
| SOCIETE GENERALE | block | Buy | 25 Jan, 2024 | ₹4,999.60 | 3,08,994 | BSE |
| MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND | block | Buy | 25 Jan, 2024 | ₹4,999.60 | 65,337 | BSE |
| MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND | block | Buy | 25 Jan, 2024 | ₹4,999.60 | 6,559 | BSE |
| MARSHALL WACE INVESTMENT STRATEGIES - EUREKA FUND | block | Buy | 25 Jan, 2024 | ₹4,999.60 | 70,355 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 29 Mar, 2022 | Mr. Deepak Kumar Singh | Disposal | ₹3,609.42316 | 25,000 | BSE |
| 08 Mar, 2022 | Mritunjay Kumar Singh | Acquisition | ₹3,158.041387705416920267802800 | 1,643 | BSE |
| 08 Mar, 2022 | Mritunjay Kumar Singh | Acquisition | ₹3,184.949061662198391420911528 | 3,357 | BSE |
| 25 Feb, 2022 | Dhananjay and Madhurima Singh Trust | Acquisition | ₹3,275.00 | 1,050 | BSE |
| 23 Feb, 2022 | Dhananjay and Madhurima Singh Trust | Acquisition | ₹3,295.8705 | 2,000 | BSE |
| 30 Dec, 2021 | Mr. Deepak Kumar Singh | Disposal | ₹3,491.1665 | 2,000 | BSE |
| 27 Dec, 2021 | Mr. Deepak Kumar Singh | Disposal | ₹3,437.3135 | 2,000 | BSE |
| 23 Dec, 2021 | Mr. Deepak Kumar Singh | Disposal | ₹3,435.8262 | 5,000 | BSE |
| 02 Dec, 2021 | Jayanti Sinha | Disposal | ₹ | 20,00,000 | BSE |
| 18 Nov, 2021 | Deepak Kumar Singh | Disposal | ₹3,572.5524 | 5,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 28 Jan, 2025 | Rs.37.0000 per share(1850%)Interim Dividend | 14 Feb, 2025 | 14 Feb, 2025 |
| 29 May, 2024 | Rs.5.0000 per share(250%)Final Dividend | 09 Aug, 2024 | 10 Aug, 2024 |
| 01 Feb, 2024 | Rs.35.0000 per share(1750%)Interim Dividend | 16 Feb, 2024 | 17 Feb, 2024 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 18 Feb, 2025 | NSE India | Alkem Laboratories Limited has informed the Exchange about Schedule of meet |
| 18 Feb, 2025 | BSE India | Please find enclosed herewith the details of investor meeting scheduled to be held 27th February, 2025. |
| 18 Feb, 2025 | NSE India | Alkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed |
| 18 Feb, 2025 | BSE India | Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you the Company has received an Order passed by the statutory authority under the Goods and Services Tax Act, 2017.\r\n\r\nThe relevant disclosure is enclosed herewith. |
| 17 Feb, 2025 | BSE India | Please find enclosed herewith the details of investor meetings scheduled to be held on 24th February, 2025. |
| 17 Feb, 2025 | NSE India | Alkem Laboratories Limited has informed the Exchange about Schedule of meet |
| 14 Feb, 2025 | NSE India | Alkem Laboratories Limited has informed the Exchange about Action(s) initiated or orders passed |
| 14 Feb, 2025 | BSE India | Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, this is to inform you that the Company has received an Order passed by the statutory authority under the Goods and Services Tax Act, 2017.\r\n\r\nThe relevant disclosure is enclosed herewith. |
| 11 Feb, 2025 | NSE India | Alkem Laboratories Limited has informed the Exchange about Transcript |
| 11 Feb, 2025 | BSE India | Please find enclosed herewith the transcript of \Q3 FY2025 Earnings Conference Call\ hosted by the Company on Friday, 07th February, 2025. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Interim Dividend | -- | 29 Jan, 2025 | 07 Feb, 2025 |
| Quarterly Results | -- | 06 Nov, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 26 Jul, 2024 | 09 Aug, 2024 |
| Audited Results & Final Dividend | -- | 20 May, 2024 | 29 May, 2024 |
| Quarterly Results & Interim Dividend | -- | 05 Feb, 2024 | 09 Feb, 2024 |
| Quarterly Results | -- | 30 Oct, 2023 | 07 Nov, 2023 |
| Quarterly Results | -- | 02 Aug, 2023 | 10 Aug, 2023 |
| Audited Results & Final Dividend | -- | 10 May, 2023 | 19 May, 2023 |
| Quarterly Results & Interim Dividend | -- | 25 Jan, 2023 | 10 Feb, 2023 |
| Quarterly Results | -- | 03 Nov, 2022 | 11 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Alkem Laboratories
Alkem Laboratories is a Public Limited Listed company incorporated on 08/08/1973 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L00305MH1973PLC174201 and registration number is 174201. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 9747.72 Cr. and Equity Capital is Rs. 23.91 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1973
Managing Director
Mr. Sandeep Singh
NSE Symbol
ALKEM
Alkem Laboratories Management
| Name | Designation |
|---|---|
| Mr. Basudeo N Singh | Executive Chairman |
| Mr. Sandeep Singh | Managing Director |
| Mrs. Madhurima Singh | Executive Director |
| Mr. Srinivas Singh | Executive Director |
| Mr. Mritunjay Kumar Singh | Executive Director |
| Mr. Sarvesh Singh | Executive Director |
| Mr. Sujjain Talwar | Independent Director |
| Mr. Arun Kumar Purwar | Independent Director |
| Ms. Sangeeta Singh | Independent Director |
| Ms. Sudha Ravi | Independent Director |
| Mr. Narendra Kumar Aneja | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| SunPhrmInds | ₹4,46,576.22 | ₹1,643.75  ₹1,669.30(-1.53%) | ₹1,249.800 - ₹1,960.200 |
| Divis Labora | ₹1,56,123.40 | ₹5,757.05 ₹5,978.30(-3.70%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,21,675.13 | ₹1,475.75 ₹1,479.70(-0.27%) | ₹1,240.700 - ₹1,702.000 |
| ManKind Phar | ₹1,18,478.90 | ₹2,327.75 ₹2,348.45(-0.88%) | ₹1,910.100 - ₹3,050.000 |
| DrReddysLab | ₹1,15,939.04 | ₹1,151.80 ₹1,170.95(-1.64%) | ₹1,104.690 - ₹1,420.200 |
FAQs on Alkem Laboratories
What is the share price of Alkem Laboratories?
The share price of Alkem Laboratories on 21 Feb, 2025 is ₹ 4,605.65.
What is 52W high and 52W low share price of Alkem Laboratories?
The highest and lowest 52W share prices of Alkem Laboratories are ₹ 6440.000 and ₹ 4409.900
What is the market cap of Alkem Laboratories?
The market capitalization of Alkem Laboratories as of 21 Feb, 2025 is ₹ 55,014.85 Crores
What is the P/E ratio of Alkem Laboratories?
The current P/E ratio of Alkem Laboratories as of 21 Feb, 2025 is 43.99
What is the PB ratio of Alkem Laboratories?
The PB ratio of Alkem Laboratories as of 21 Feb, 2025 is 5.13
Top Gainers
948IHFL26I
IBHFL NCD186
₹845.00
₹705.00 (0.20%)
GREAVESCOT
Greaves
₹281.85
₹234.90 (0.20%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.20%)
CAPRO
Caprola.Chem
₹62.40
₹52.00 (0.20%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.10%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.10%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0.00%)